You've reached a pubget topic page. Below are the latest papers on this topic, with subtopics on the left.
keywords > Heterocyclic Compounds > Heterocyclic Compounds, 1-Ring > Oxazines > Benzoxazines
Inhibition of mitochondrial function by efavirenz increases lipid content in hepatic cells.
Inhibition of mitochondrial function by efavirenz increases lipid content in hepatic cells.
Inhibition of mitochondrial function by efavirenz increases lipid content in hepatic cells.
Inhibition of mitochondrial function by efavirenz increases lipid content in hepatic cells.
Inhibition of mitochondrial function by efavirenz increases lipid content in hepatic cells.
Inhibition of mitochondrial function by efavirenz increases lipid content in hepatic cells.
Inhibition of mitochondrial function by efavirenz increases lipid content in hepatic cells.
Inhibition of mitochondrial function by efavirenz increases lipid content in hepatic cells.
Inhibition of mitochondrial function by efavirenz increases lipid content in hepatic cells.
Inhibition of mitochondrial function by efavirenz increases lipid content in hepatic cells.
Inhibition of mitochondrial function by efavirenz increases lipid content in hepatic cells.
Inhibition of mitochondrial function by efavirenz increases lipid content in hepatic cells.
Inhibition of mitochondrial function by efavirenz increases lipid content in hepatic cells.
Inhibition of mitochondrial function by efavirenz increases lipid content in hepatic cells.
Inhibition of mitochondrial function by efavirenz increases lipid content in hepatic cells.
Inhibition of mitochondrial function by efavirenz increases lipid content in hepatic cells.
Inhibition of mitochondrial function by efavirenz increases lipid content in hepatic cells.
Inhibition of mitochondrial function by efavirenz increases lipid content in hepatic cells.
Inhibition of mitochondrial function by efavirenz increases lipid content in hepatic cells.
Inhibition of mitochondrial function by efavirenz increases lipid content in hepatic cells.